Unknown PHASE3 INTERVENTIONAL 2-arm NCT02125409

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action.

Sponsor: Aragon Institute of Health Sciences

Interventions Acetylsalicylic acid Screening colonoscopy

Updated 5 times since 2017 Last updated: May 2, 2014 Started: May 31, 2014 Primary completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02125409, this PHASE3 trial focuses on Colorectal Cancer and remains ongoing. Sponsored by Aragon Institute of Health Sciences, it has been updated 5 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aragon Institute of Health Sciences
Catholic University, Italy
G. d'Annunzio University

Data source: Aragon Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zaragoza, Spain